2015-2027 Global Opioids Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

Publisher Name :
Date: 09-Jun-2020
No. of pages: 134

The worldwide market for Opioids is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered

AbbVie

Endo Pharmaceuticals

Teva pharmaceuticals

Sun Pharmaceutical Industries Limited.

Hospira

Sanofi

Pfizer

Purdue Pharma

Allergan

Orexo Pharmaceuticals

Major Types Covered

Morphine

Hydrocodone

Codeine

Oxycodone

Others

Major Applications Covered

Neuropathic Pain Treatment

Orthopedic Pain Treatment

Other Pain Treatment

Top Countries Data Covered in This Report

United States

Canada

Germany

UK

France

Italy

Spain

Russia

Netherlands

Turkey

Switzerland

Sweden

Poland

Belgium

China

Japan

South Korea

Australia

India

Taiwan

Indonesia

Thailand

Philippines

Malaysia

Brazil

Mexico

Argentina

Columbia

Chile

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2027

2015-2027 Global Opioids Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 Key Findings of the Study

3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Opioids Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Opioids Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 Value Chain of the Opioids Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 Global Opioids Market-Segmentation by Type
5.1 Morphine
5.2 Hydrocodone
5.3 Codeine
5.4 Oxycodone
5.5 Others

6 Global Opioids Market-Segmentation by Application
6.1 Neuropathic Pain Treatment
6.2 Orthopedic Pain Treatment
6.3 Other Pain Treatment

7 Global Opioids Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 Competitive Intelligence - Company Profiles
8.1 AbbVie
8.1.1 AbbVie Profile
8.1.2 AbbVie Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 AbbVie Product/Solution Launches and Enhancements Analysis
8.1.4 AbbVie Business Overview/Recent Development/Acquisitions
8.2 Endo Pharmaceuticals
8.2.1 Endo Pharmaceuticals Profile
8.2.2 Endo Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Endo Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.2.4 Endo Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.3 Teva pharmaceuticals
8.3.1 Teva pharmaceuticals Profile
8.3.2 Teva pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Teva pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.3.4 Teva pharmaceuticals Business Overview/Recent Development/Acquisitions
8.4 Sun Pharmaceutical Industries Limited.
8.4.1 Sun Pharmaceutical Industries Limited. Profile
8.4.2 Sun Pharmaceutical Industries Limited. Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Sun Pharmaceutical Industries Limited. Product/Solution Launches and Enhancements Analysis
8.4.4 Sun Pharmaceutical Industries Limited. Business Overview/Recent Development/Acquisitions
8.5 Hospira
8.5.1 Hospira Profile
8.5.2 Hospira Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Hospira Product/Solution Launches and Enhancements Analysis
8.5.4 Hospira Business Overview/Recent Development/Acquisitions
8.6 Sanofi
8.6.1 Sanofi Profile
8.6.2 Sanofi Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Sanofi Product/Solution Launches and Enhancements Analysis
8.6.4 Sanofi Business Overview/Recent Development/Acquisitions
8.7 Pfizer
8.7.1 Pfizer Profile
8.7.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.7.4 Pfizer Business Overview/Recent Development/Acquisitions
8.8 Purdue Pharma
8.8.1 Purdue Pharma Profile
8.8.2 Purdue Pharma Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Purdue Pharma Product/Solution Launches and Enhancements Analysis
8.8.4 Purdue Pharma Business Overview/Recent Development/Acquisitions
8.9 Allergan
8.9.1 Allergan Profile
8.9.2 Allergan Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Allergan Product/Solution Launches and Enhancements Analysis
8.9.4 Allergan Business Overview/Recent Development/Acquisitions
8.10 Orexo Pharmaceuticals
8.10.1 Orexo Pharmaceuticals Profile
8.10.2 Orexo Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Orexo Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.10.4 Orexo Pharmaceuticals Business Overview/Recent Development/Acquisitions

9 Global Opioids Market-Segmentation by Geography

10 North America
10.1 North America Opioids Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Opioids Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Opioids Production Analysis from 2015-2020
10.4 North America Opioids Consumption Analysis from 2015-2020
10.5 North America Opioids Import and Export from 2015-2020
10.6 North America Opioids Value, Production and Market Share by Type (2015-2020)
10.7 North America Opioids Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Opioids by Country (United States, Canada)
10.8.1 North America Opioids Sales by Country (2015-2020)
10.8.2 North America Opioids Consumption Value by Country (2015-2020)
10.9 North America Opioids Market PEST Analysis

11 Europe
11.1 Europe Opioids Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Opioids Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Opioids Production Analysis from 2015-2020
11.4 Europe Opioids Consumption Analysis from 2015-2020
11.5 Europe Opioids Import and Export from 2015-2020
11.6 Europe Opioids Value, Production and Market Share by Type (2015-2020)
11.7 Europe Opioids Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Opioids by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Opioids Sales by Country (2015-2020)
11.8.2 Europe Opioids Consumption Value by Country (2015-2020)
11.9 Europe Opioids Market PEST Analysis

12 Asia-Pacific
12.1 Asia-Pacific Opioids Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Opioids Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Opioids Production Analysis from 2015-2020
12.4 Asia-Pacific Opioids Consumption Analysis from 2015-2020
12.5 Asia-Pacific Opioids Import and Export from 2015-2020
12.6 Asia-Pacific Opioids Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Opioids Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Opioids by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Opioids Sales by Country (2015-2020)
12.8.2 Asia-Pacific Opioids Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Opioids Market PEST Analysis

13 Latin America
13.1 Latin America Opioids Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Opioids Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Opioids Production Analysis from 2015-2020
13.4 Latin America Opioids Consumption Analysis from 2015-2020
13.5 Latin America Opioids Import and Export from 2015-2020
13.6 Latin America Opioids Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Opioids Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Opioids by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Opioids Sales by Country (2015-2020)
13.8.2 Latin America Opioids Consumption Value by Country (2015-2020)
13.9 Latin America Opioids Market PEST Analysis

14 Middle East & Africa
14.1 Middle East & Africa Opioids Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Opioids Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Opioids Production Analysis from 2015-2020
14.4 Middle East & Africa Opioids Consumption Analysis from 2015-2020
14.5 Middle East & Africa Opioids Import and Export from 2015-2020
14.6 Middle East & Africa Opioids Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Opioids Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Opioids by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Opioids Sales by Country (2015-2020)
14.8.2 Middle East & Africa Opioids Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Opioids Market PEST Analysis

15 Future Forecast of the Global Opioids Market from 2020-2027
15.1 Future Forecast of the Global Opioids Market from 2020-2027 Segment by Region
15.2 Global Opioids Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Opioids Consumption and Growth Rate Forecast by Application (2020-2027)

16 Appendix
16.1 Methodology
16.2 Research Data Source

List of Tables and Figures
Global Opioids Market Value ($) and Growth Rate of Opioids from 2015-2027
Global Opioids Production and Growth Rate Segment by Product Type from 2015-2027
Global Opioids Consumption and Growth Rate Segment by Application from 2015-2027
Figure Opioids Picture
Table Product Specifications of Opioids
Table Driving Factors for this Market
Table Industry News of Opioids Market
Figure Value Chain Status of Opioids
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Opioids Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Opioids Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Morphine of Opioids
Figure Hydrocodone of Opioids
Figure Codeine of Opioids
Figure Oxycodone of Opioids
Figure Others of Opioids
Table Global Opioids Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Opioids Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Neuropathic Pain Treatment of Opioids
Figure Orthopedic Pain Treatment of Opioids
Figure Other Pain Treatment of Opioids
Table Global Opioids Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Opioids Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Opioids
Figure Online Channel of Opioids
Table AbbVie Profile (Company Name, Plants Distribution, Sales Region)
Figure AbbVie Sales and Growth Rate from 2015-2020
Figure AbbVie Revenue ($) and Global Market Share from 2015-2020
Table AbbVie Opioids Sales, Price, Revenue, Gross Margin (2015-2020)
Table Endo Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Endo Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Endo Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Endo Pharmaceuticals Opioids Sales, Price, Revenue, Gross Margin (2015-2020)
Table Teva pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Teva pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Teva pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Teva pharmaceuticals Opioids Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sun Pharmaceutical Industries Limited. Profile (Company Name, Plants Distribution, Sales Region)
Figure Sun Pharmaceutical Industries Limited. Sales and Growth Rate from 2015-2020
Figure Sun Pharmaceutical Industries Limited. Revenue ($) and Global Market Share from 2015-2020
Table Sun Pharmaceutical Industries Limited. Opioids Sales, Price, Revenue, Gross Margin (2015-2020)
Table Hospira Profile (Company Name, Plants Distribution, Sales Region)
Figure Hospira Sales and Growth Rate from 2015-2020
Figure Hospira Revenue ($) and Global Market Share from 2015-2020
Table Hospira Opioids Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi Sales and Growth Rate from 2015-2020
Figure Sanofi Revenue ($) and Global Market Share from 2015-2020
Table Sanofi Opioids Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Opioids Sales, Price, Revenue, Gross Margin (2015-2020)
Table Purdue Pharma Profile (Company Name, Plants Distribution, Sales Region)
Figure Purdue Pharma Sales and Growth Rate from 2015-2020
Figure Purdue Pharma Revenue ($) and Global Market Share from 2015-2020
Table Purdue Pharma Opioids Sales, Price, Revenue, Gross Margin (2015-2020)
Table Allergan Profile (Company Name, Plants Distribution, Sales Region)
Figure Allergan Sales and Growth Rate from 2015-2020
Figure Allergan Revenue ($) and Global Market Share from 2015-2020
Table Allergan Opioids Sales, Price, Revenue, Gross Margin (2015-2020)
Table Orexo Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Orexo Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Orexo Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Orexo Pharmaceuticals Opioids Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Opioids Production Value ($) by Region from 2015-2020
Table Global Opioids Production Value Share by Region from 2015-2020
Table Global Opioids Production by Region from 2015-2020
Table Global Opioids Consumption Value ($) by Region from 2015-2020
Table Global Opioids Consumption by Region from 2015-2020
Table North America Opioids Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Opioids Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Opioids Import and Export from 2015-2020
Table North America Opioids Value ($) by Type (2015-2020)
Table North America Opioids Production by Type (2015-2020)
Table North America Opioids Consumption by Application (2015-2020)
Table North America Opioids Consumption by Country (2015-2020)
Table North America Opioids Consumption Value ($) by Country (2015-2020)
Figure North America Opioids Market PEST Analysis
Table Europe Opioids Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Opioids Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Opioids Import and Export from 2015-2020
Table Europe Opioids Value ($) by Type (2015-2020)
Table Europe Opioids Production by Type (2015-2020)
Table Europe Opioids Consumption by Application (2015-2020)
Table Europe Opioids Consumption by Country (2015-2020)
Table Europe Opioids Consumption Value ($) by Country (2015-2020)
Figure Europe Opioids Market PEST Analysis
Table Asia-Pacific Opioids Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Opioids Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Opioids Import and Export from 2015-2020
Table Asia-Pacific Opioids Value ($) by Type (2015-2020)
Table Asia-Pacific Opioids Production by Type (2015-2020)
Table Asia-Pacific Opioids Consumption by Application (2015-2020)
Table Asia-Pacific Opioids Consumption by Country (2015-2020)
Table Asia-Pacific Opioids Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Opioids Market PEST Analysis
Table Latin America Opioids Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Opioids Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Opioids Import and Export from 2015-2020
Table Latin America Opioids Value ($) by Type (2015-2020)
Table Latin America Opioids Production by Type (2015-2020)
Table Latin America Opioids Consumption by Application (2015-2020)
Table Latin America Opioids Consumption by Country (2015-2020)
Table Latin America Opioids Consumption Value ($) by Country (2015-2020)
Figure Latin America Opioids Market PEST Analysis
Table Middle East & Africa Opioids Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Opioids Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Opioids Import and Export from 2015-2020
Table Middle East & Africa Opioids Value ($) by Type (2015-2020)
Table Middle East & Africa Opioids Production by Type (2015-2020)
Table Middle East & Africa Opioids Consumption by Application (2015-2020)
Table Middle East & Africa Opioids Consumption by Country (2015-2020)
Table Middle East & Africa Opioids Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Opioids Market PEST Analysis
Table Global Opioids Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Opioids Production and Growth Rate Forecast by Region (2020-2027)
Table Global Opioids Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Opioids Production and Growth Rate Forecast by Type (2020-2027)
Table Global Opioids Consumption and Growth Rate Forecast by Application (2020-2027)
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs